Repro Med Systems (KRMD) Tops Q4 EPS by 2c; Offers Guidance

Repro Med Systems (NASDAQ: KRMD) reported Q4 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $7.38 million.

GUIDANCE:

Repro Med Systems sees FY2023 revenue of $32.5-33.5 million, versus the consensus of $30.914 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Greenlane Holdings Inc. (GNLN) reported Q2 result
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c